Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its position in Addus HomeCare Co. (NASDAQ:ADUS) by 1.3% in the third quarter, HoldingsChannel reports. The institutional investor owned 57,842 shares of the company’s stock after selling 777 shares during the period. Mutual of America Capital Management LLC’s holdings in Addus HomeCare were worth $7,695,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Natixis Advisors LLC grew its stake in shares of Addus HomeCare by 4.8% in the third quarter. Natixis Advisors LLC now owns 38,561 shares of the company’s stock valued at $5,130,000 after buying an additional 1,777 shares in the last quarter. Empowered Funds LLC grew its stake in shares of Addus HomeCare by 25.1% in the third quarter. Empowered Funds LLC now owns 13,887 shares of the company’s stock valued at $1,847,000 after buying an additional 2,790 shares in the last quarter. Royce & Associates LP grew its stake in shares of Addus HomeCare by 1.2% in the third quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock valued at $1,187,000 after buying an additional 109 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Addus HomeCare by 6.1% in the third quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock valued at $11,302,000 after buying an additional 4,913 shares in the last quarter. Finally, Entropy Technologies LP acquired a new stake in shares of Addus HomeCare in the third quarter valued at $226,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $118.27 on Tuesday. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 27.06, a price-to-earnings-growth ratio of 2.09 and a beta of 1.04. The business has a 50-day moving average of $128.82 and a two-hundred day moving average of $122.73. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period in the previous year, the business earned $1.03 EPS. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of recent research reports. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Oppenheimer lifted their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Macquarie reiterated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.